Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 51 of 102, showing 5 Applications out of 508 total, starting on record 251, ending on 255

# Protocol No Study Title Investigator(s) & Site(s)

251.

ECCT/21/03/01   Recombinant COVID-19 vaccine
    A global multicenter, randomized, double-blind, placebo-controlled, phase III clinical trial to evaluate the efficacy, safety, and immunogenicity ofread more
Principal Investigator(s)
1. Walter Jaoko Jaoko
Site(s) in Kenya
KAVI-institute of Clinical Research
 
View

252.

ECCT/22/08/02   AIM-LVRNA009-II_III-01
    A Global Multi-center, Randomized, Blinded, Placebo-controlled Phase 2/3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 mRNAread more
Principal Investigator(s)
1. Bernhards Ogutu
2. Lucas Otieno
3. Videlis Nduba
4. Bernhards Ogutu
5. Jacqueline Mirera
6. Jacqueline Mirera
read more
View

253.

ECCT/17/03/01   The POWER cohort
    A cohort for evaluation of open-label PrEP delivery among Kenyan and South African women   
Principal Investigator(s)
1. Dr. Stella Njuguna
Site(s) in Kenya
1. Jaramogi Oginga Odinga Teaching and Referral Hospital. (Kisumu county)
 
View

254.

ECCT/20/04/02   PROSYNK Study
    A 4-arm, open-label, individually randomized, controlled, phase-2, study of a probiotic and two synbiotics in young children in western Kenya.   
Principal Investigator(s)
1. Stephen Allen
Site(s) in Kenya
1. Homa Bay County Referral Hospital (Homa Bay county)
2. Siaya County Referral Hospital (read more
View

255.

ECCT/13/04/08  
    Switching At Low HIV-1 RNA Into Fixed Dose Combinations   SALIF   Protocol Number: TMC278IFD3002 Amendment INT-1   
Principal Investigator(s)
1. Edwin Onyango WERE
2. Milton Tony OMONDI
3. Gina OUATTARA
4. Gaudensia Nzembi MUTUA
5. Reena SHAH
Site(s) in Kenyaread more
View